WOODLAND PARK, N.J., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anterix (NASDAQ: ATEX) today announced its first quarter fiscal 2027 results and filed its Form 10-Q for the three months ended June 30, 2026.
WOODLAND PARK, N.J., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anterix (NASDAQ: ATEX) today announced its first quarter fiscal 2027 results and filed its Form 10-Q for the three months ended June 30, 2026....
WOODLAND PARK, N.J., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anterix (NASDAQ: ATEX) issued the following statement from Christopher Guttman-McCabe, Chief Regulatory and Corporate Communications Officer, in...
WOODLAND PARK, N.J., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anterix (NASDAQ: ATEX) issued the following statement from Christopher Guttman-McCabe, Chief...
Anterix (ATEX) has surged 380% over the past year, recently hitting an all-time high of $113. ATEX maintains strong technical momentum with a 100% “Buy” rating from Barchart. Revenue is forecast to...
WOODLAND PARK, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Anterix (NASDAQ: ATEX) announced today that it will hold a conference call on Wednesday, August...
WOODLAND PARK, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Anterix (NASDAQ: ATEX) announced today that it will hold a conference call on Wednesday, August 12, 2026, at 9:00 a.m. ET. Anterix senior management...
WOODLAND PARK, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- Anterix (NASDAQ: ATEX) today announced fiscal 2026 fourth quarter and full fiscal year financial results for the year ended March 31, 2026. ...